Pages that link to "Q40390211"
Jump to navigation
Jump to search
The following pages link to Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy (Q40390211):
Displaying 50 items.
- Comparative tolerability of the newer fluoroquinolone antibacterials (Q28146268) (← links)
- A critical review of the fluoroquinolones: focus on respiratory infections (Q28215446) (← links)
- Antimicrobial safety: focus on fluoroquinolones (Q28255152) (← links)
- Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance (Q28361569) (← links)
- Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus (Q28379074) (← links)
- In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains (Q28379294) (← links)
- Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network (Q30671029) (← links)
- Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients (Q31918096) (← links)
- Antibiotic side effects (Q31974254) (← links)
- Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults (Q33420344) (← links)
- Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults (Q33487556) (← links)
- Expanded activity and utility of the new fluoroquinolones: a review (Q33544588) (← links)
- Clinical and economic considerations in the use of third-generation oral cephalosporins (Q33569088) (← links)
- Treatment of Helicobacter pylori infection: current status and future concepts (Q33863850) (← links)
- In Vitro Activity of Levofloxacin against a Selected Group of Anaerobic Bacteria Isolated from Skin and Soft Tissue Infections (Q33693101) (← links)
- Potential interactions of the extended-spectrum fluoroquinolones with the CNS. (Q33717059) (← links)
- Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review (Q33739099) (← links)
- Antibiotic precautions in athletes (Q33786181) (← links)
- Severe pneumococcal pneumonia: impact of new quinolones on prognosis (Q33846631) (← links)
- Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa (Q33976151) (← links)
- Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid (Q33979516) (← links)
- Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species (Q33981082) (← links)
- The safety profile of the fluoroquinolones. (Q34005865) (← links)
- Safety profile of the fluoroquinolones: focus on levofloxacin (Q34110521) (← links)
- Quinolone Resistance: Older Concepts and Newer Developments (Q34140894) (← links)
- Disposition Kinetics of Levofloxacin in Sheep after Intravenous and Intramuscular Administration (Q34271413) (← links)
- Absorption Interactions With Fluoroquinolones 1995 Update (Q34304883) (← links)
- Fluoroquinolone adverse effects and drug interactions (Q34408447) (← links)
- Mirtazapine therapy for dysgeusia in an elderly patient (Q34557847) (← links)
- The expanding role of fluoroquinolones (Q34735112) (← links)
- Levofloxacin: an updated review of its use in the treatment of bacterial infections (Q34880958) (← links)
- Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci (Q35005511) (← links)
- In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem. (Q35123438) (← links)
- In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia (Q35130484) (← links)
- Prevalence of and Risk Factors for Levofloxacin-ResistantE. coliIsolated from Outpatients with Urinary Tract Infection (Q35182408) (← links)
- Rapid and sensitive determination of levofloxacin in microsamples of human plasma by high-performance liquid chromatography and its application in a pharmacokinetic study. (Q35193051) (← links)
- Systematic analysis of the role of bacterial Hfq-interacting sRNAs in the response to antibiotics (Q35569225) (← links)
- Vitreous penetration of levofloxacin in the uninflamed phakic human eye. (Q35589606) (← links)
- Metabolism of high density lipoproteins in liver cancer (Q35621221) (← links)
- The new fluoroquinolones: A critical review (Q35649595) (← links)
- Lipids changes in liver cancer (Q35815160) (← links)
- Levofloxacin for the treatment of community-acquired pneumonia (Q36670872) (← links)
- Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis (Q37052814) (← links)
- A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of Molecules (Q37630801) (← links)
- Levofloxacin and Sparfloxacin: New Quinolone Antibiotics (Q37881273) (← links)
- The clinical pharmacokinetics of levofloxacin (Q37883517) (← links)
- Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration (Q38581416) (← links)
- Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophils (Q39469712) (← links)
- Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin (Q39780493) (← links)
- Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid (Q39781018) (← links)